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Background: Calcium pyrophosphate (CPP) microcrystal deposition is associated with
wide clinical phenotypes, including acute and chronic arthritis, that are interleukin 1β
(IL-1β)-driven. Two CPP microcrystals, namely monoclinic and triclinic CPP dihydrates
(m- and t-CPPD), have been identified in human tissues in different proportions according
to clinical features. m-CPP tetrahydrate beta (m-CPPTβ) and amorphous CPP (a-CPP)
phases are considered as m- and t-CPPD crystal precursors in vitro.
Objectives: We aimed to decipher the inflammatory properties of the three crystalline
phases and one amorphous CPP phase and the intracellular pathways involved.
Methods: The four synthesized CPP phases and monosodium urate crystals (MSU, as
a control) were used in vitro to stimulate the human monocytic leukemia THP-1 cell line or
bone marrow-derived macrophages (BMDM) isolated from WT or NLRP3 KO mice. The
gene expression of pro- and anti-inflammatory cytokines was evaluated by quantitative
PCR; IL-1β, IL-6 and IL-8 production by ELISA; and mitogen-activated protein kinase
(MAPK) activation by immunoblot analysis. NF-κB activation was determined in THP-1
cells containing a reporter plasmid. In vivo, the inflammatory potential of CPP phases
was assessed with the murine air pouch model via cell analysis and production of IL-1β
and CXCL1 in the exudate. The role of NF-κB was determined by a pharmacological
approach, both in vivo and in vitro.
Results: In vitro, IL-1β production induced by m- and t-CPPD and m-CPPTβ
crystals was NLRP3 inflammasome dependent. m-CPPD crystals were the most
inflammatory by inducing a faster and higher production and gene expression of
IL-1β, IL-6, and IL-8 than t-CPPD, m-CPPTβ and MSU crystals. The a-CPP phase
did not show an inflammatory property. Accordingly, m-CPPD crystals led to stronger
activation of NF-κB, p38, extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun
N-terminal kinase (JNK) MAPKs. Inhibition of NF-κB completely abrogated IL-1β and
IL-8 synthesis and secretion induced by all CPP crystals. Also, inhibition of JNK
and ERK1/2 MAPKs decreased both IL-1β secretion and NF-κB activation induced
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by CPP crystals. In vivo, IL-1β and CXCL1 production and neutrophil infiltration induced
by m-CPPD crystals were greatly decreased by NF-κB inhibitor treatment.
Conclusion: Our results suggest that the inflammatory potential of different CPP crystals
relies on their ability to activate the MAPK-dependent NF-κB pathway. Studies are
ongoing to investigate the underlying mechanisms.
Keywords: CPP crystals, microcrystal-induced arthritis, IL-1β, MAP kinase signaling, NF-κB pathway,
macrophages, NLRP3 inflammasome
INTRODUCTION
Calcium pyrophosphate dihydrate (CPPD) microcrystal
deposition disease affects more than 17.5% of people over
75 years old (1, 2). Monoclinic and triclinic CPPD phases
(m-CPPD and t-CPPD, respectively) are the two types of
CPPD crystals identified in synovial fluids at the time of acute
arthritis, but the existence of precursor phases such as m-CPP
tetrahydrate beta (m-CPPTβ) and amorphous CPP (a-CPP)
have been suggested in vitro (3, 4). CPPD microcrystals are
responsible for numerous clinical manifestations including
asymptomatic CPPD, osteoarthritis with CPPD, and acute
and chronic CPP crystal-induced arthritis, involving from one
to several joints (5). A few studies suggest that differences
in the size, structure, surface area, shape of crystals and
proportion of the different crystals may explain these wide
clinical phenotypes. For example, smaller crystals are more
active than larger ones: the crystal surface plays a major
role in determining cellular response and m-CPPD may be
more active than t-CPPD (6–10). In line with these pre-
clinical results, acute inflammatory synovial fluids contain a
greater proportion of m-CPPD crystals and low inflammatory
samples contain a greater proportion of t-CPPD crystals
(7).
Like monosodium urate (MSU) and basic calcium phosphate
(BCP) microcrystals, m- and t-CPPD microcrystals are
responsible for recurrent inflammatory flares by their ability
to induce production of a large panel of pro-inflammatory
mediators such as interleukin-1β (IL-1β), IL-6, IL-8, or tumor
necrosis factor-α (TNF-α) (11–13). The in vivo inflammatory
response induced by microcrystals is clearly reported in mouse
intra-articular, intraperitoneal or air pouch models of crystal
injection. Using IL-1 receptor knock-out (KO) mice, mice
treated with IL-1RA (IL-1 receptor antagonist) or depleted-
macrophage mice, those studies demonstrated that acute
inflammatory phase is mainly orchestrated by IL-1β secreted by
resident macrophages after crystal detection (12, 14, 15). IL-1β
production occurs through a 2-step process involving (i) nuclear
factor-κB (NF-κB) activation that leads to pro-IL1β formation
and (ii) NLRP3 (NOD-like Receptor family, Pyrin domain
containing 3) inflammasome activation that permits caspase-1 to
cleave pro-IL-1β into mature IL-1β (16). IL-1β, as well as crystals
themselves, are then able to activate the production of multiple
pro-inflammatory cytokines by macrophages, endothelial
cells, fibroblasts, synoviocytes. Especially, IL-8 production is
responsible for a massive polymorphonuclear neutrophil (PMN)
recruitment in the site of crystal injection which participates to
the amplification of inflammatory response (17).
Microcrystals activate cellular responses after a direct crystal-
cell membrane contact or a specific crystal-cell receptor
interaction, either through naked crystals or via proteins
adsorbed on the crystal surface (13, 18–21). As reported, naked
MSU, BCP and CPPD crystals stimulate cellular receptors such
as integrin CD11b/CD18, the Fc receptor CD16, the cell surface-
expressed immunoglobulin triggering receptor expressed on
myeloid cell 1 and Toll-like receptors (TLR) 2 and 4 (13, 22–
25). The interaction of crystals with cell membrane and/or cell
receptors stimulates numerous intracellular signaling pathways
including NLRP3 inflammasome complex, intracellular calcium
mobilization, Src and Syk kinases, myeloid differentiation
factor 88 (MyD88)-dependent downstream signaling as well as
extracellular signal-regulated kinase 1/2 (ERK1/2), p38 and c-
Jun N-terminal kinase (JNK) mitogen-activated protein kinases
(MAPKs) (11, 12, 18, 26–29). These intracellular pathways
activate transcription factors such as activator protein 1 and
NF-κB, which regulate inflammatory gene expression (19, 28).
A few studies have shown that m-CPPD microcrystals
are more inflammatory than t-CPPD microcrystals, inducing
greater and longer PMN recruitment and greater production
of prostaglandin-E2, reactive oxygen species and TNF-α;
however, the underlying mechanisms and cellular signaling
pathways have not been investigated (9, 10). Similarly, no
study has yet assessed the potential of each CPPD crystal to
induce the production of IL-1β, the main cytokine orchestrating
the crystal-induced inflammatory reaction. Furthermore,
whether precursors of CPPD crystals such as m-CPPTβ
and a-CPP phases can stimulate inflammatory mediators
and cellular responses is unknown. Thus, we aimed to
precisely characterize the inflammatory potential of these
four pure phases of CPP by studying synthesis signaling of
pro-inflammatory cytokines, in particular the production of
pro- and mature IL-1β, and the MAPK/NF-κB activation
pathway.
MATERIALS AND METHODS
In vitro Crystal Synthesis and
Characterization
MSU crystals were obtained by spontaneous precipitation of uric
acid in NaOH solution (0.01M) at 60◦C as described (30). Four
different CPP pure phases were synthesized and characterized
as previously reported (4). These compounds were characterized
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by X-ray diffraction (Seifert XRD-3000TT diffractometer with
Cu Kα radiation, in the 2θ range 2◦-70◦ with step size 0.02◦
and scan step time 16 s at 298K), FTIR spectroscopy (Thermo
Nicolet 5700 Fourier-transform infrared spectrometer, range
4,000–400 cm−1, 64 scans, 4 cm−1 resolution, transmissionmode
with powder samples in KBr pellets) and scanning electron
microscopy (SEM, Leo 435 VP microscope, accelerating voltage:
7 kV, samples were silver-plated before observation). Chemical
analysis of pyrophosphate and calcium was performed as follows:
standard spectrophotometric (Hitachi U-1100 spectrometer, λ=
460 nm) determination of the yellow phosphovanadomolybdic
acid complex was used to determine phosphate concentration
after hydrolysis of the pyrophosphate (at 100◦C in acidic medium
during 1 h) into phosphate ions; calcium concentration was
determined by complexometry with ethylene diamine tetra-
acetic acid (EDTA). The specific surface area of the sample
was evaluated on a Quanta chrome Instruments Monosorb
Nova 1,000 with the Brunauer–Emmett–Teller method (nitrogen
adsorption). Crystals/particles were dispersed by brief sonication
and suspended at 2 mg/ml in phosphate buffered saline (PBS).
They were prepared under endotoxin-free conditions and tested
negative with Pierce Limulus amebocyte Assay (Thermo Fisher
Scientific).
Thorough physicochemical characterization of the four
synthesized CPP samples showed that each consisted of a pure
phase: three were pure crystalline phases (m-CPPD, t-CPPD, and
m-CPPTβ) and one was an amorphous phase (a-CPP) (4).
Mice and Cells
Eight-week-old C57Bl/6J mice were used for in vivo or
in vitro experiments. Wild-type (wt) mice were purchased
from Janvier Lab (Le Genest-St-Isle, France). NLRP3 KO
(nlrp3−/−) mice were gifted by Dr. JL Connat (INSERM 866,
Université Bourgogne Franche-Comté, Dijon, France). Mice
were maintained in cages (max. 6/cage) in a facility with 12 h
light/dark cycles. Mice were fed diets ad libitum.
For in vitro experiments, wt and nlrp3−/− bone marrow
cells were recovered from tibia and femoral bones of mice and
seeded in 24-well plates at 2 × 106 cells/ml in L929-conditioned
RPMI 1640 media as described (31). Every 2 days, cells were
washed and the media renewed until complete differentiation
of bone marrow-derived macrophages (BMDMs). BMDMs were
maintained in RPMI 1640 supplemented with 10% fetal bovine
serum (FBS), HEPES (25mM), L-glutamine (2mM), penicillin
(100 U/ml), and streptomycin (100µg/ml) and were primed
overnight with ultrapure lipopolysaccharide (LPS; 20 ng/ml).
Human monocytic leukemia (THP-1) cells were maintained
in the same complete RPMI 1640 media and were primed for
6 h with phorbol 12-myristate 13-acetate (PMA, 0.5µM), washed
with PBS1X, then plated in 24-well dishes at 3 × 105 cells/well
and left overnight in complete media. THP-1 cells containing an
NF-κB-inducible Luc reporter construct (THP-1-LuciaTM NF-κB
Cells, Invivogen) were used to assess NF-κB activation. THP-
1-Lucia cells were maintained in the same complete RPMI
1640 media supplemented with pyruvate 1mM (Gibco) and the
selection antibiotic zeocin (Invivogen).
Primed BMDMs and THP-1 cells were washed twice with
PBS and stimulated at the indicated times with MSU or CPP
crystals (200µg/ml) in FBS-free media. For some experiments,
THP-1 cells were incubated with inhibitors of NF-κB (BAY-11-
7085, 10µM), p38 (SB203580, 10µM), JNK (SP600125, 10µM),
or p42/44 (PD98059, 100µM) (all Tocris, R&D Systems) 30min
before crystal stimulation. After crystal stimulation, supernatants
were collected for cytokine quantification and cells were lysed for
mRNA quantification or protein expression analysis.
THP-1-Lucia cells were washed twice and stimulated for 8 h
with MSU or CPP crystals (200µg/mL) or heat-killed Listeria
monocytogenes (HKLM, Invivogen: positive control of NF-κB
induction) in FBS-free medium. Absolute luciferase activity was
determined in the supernatants with a Xenius luminometer
(SAFAS Monaco) according to the manufacturer’s instructions.
Relative luminescence units were normalized by the proportion
of live cells determined with the Pierce LDH assay kit (Thermo
Fisher Scientific), then the NF-κB reporter relative activity was
calculated.
Mouse Air Pouch Model
Eight-week-old wild type C57Bl/6J mice were used for in
vivo experiments. After purchase, mice were housed 1 week
before experimentation. Air pouches were created by two dorsal
subcutaneous injections of 3ml sterile air (day 0 and day 3),
under isoflurane anesthesia. At day 6, PBS or crystals (1 mg/ml,
diluted in PBS) were injected directly into the air pouch. In
case of NF-κB study, PBS or BAY-11-7085 (NF-κB inhibitor,
200 µg/mice) were injected directly into the air pouches 30min
before PBS or crystal injection. At 6 and 24 h post-crystal
injection, air pouches were washed twice with 2ml of PBS
under ketamine/xylazine anesthesia then mice were sacrificed
by cervical dislocation. Mice displayed normal behavior after air
pouch creation and crystal injection. No painkiller was necessary.
The air pouch lavages were used for cytokine measurement and
cell counting/staining.
Cytokine Quantification
Cytokine production in supernatant or air pouch lavage was
measured by using ELISA kits [IL-1β, IL-8 (Invitrogen), CXCL1
(R&D System), IL-6 (Roche Diagnostics)].
mRNA Quantification
Primed THP-1 cells were lysed with TRizol reagent (Invitrogen),
6 h after crystal stimulation, and total RNA was extracted by
using the ISOLATE II RNA kit (Bioline). First, 500 ng of total
RNA were reverse transcript to cDNA using the High Capacity
cDNA Reverse Transcription Kit (Applied Biosystem) (LifeECO
Thermal Cycler, Bioer Technology). Then, real time quantitative
PCR was performed with 25 ng of cDNA using the SensiFAST
SYBR No-ROX Kit (Bioline) for 40 cycles (95◦C for 5 s, 60◦C
for 30 s) (LightCycler R©480 Instrument, Roche). Sequences of
primers for real time qPCR are listed in Table 1.
Flow Cytometry
A total of 1 × 105 cells from air pouch lavages was stained
with anti-F4/80-APC and anti-Ly6G-PE mouse monoclonal
antibodies (mAbs; Miltenyi Biotechnology) for 20min at room
temperature, washed in PBS and analyzed with the BD FACS
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TABLE 1 | Human primers used for gene expression analysis.
Forward Reverse
Human IL-1β TTCGAGGCACAAGGCACAA TGGCTGCTTCAGACACTTGAG
IL-8 GAGCCAGGAAGAAACCACCG TGGCAAAACTGCACCTTCACA
IL-6 GGCACTGGCAGAAAACAACC GCAAGTCTCCTCATTGAATCC
TNF-α CCCATGTTGTAGCAAACCCTC TATCTCTCAGCTCCACGCCA
NLRP3 CTTCCTTTCCAGTTTGCTGC TCTCGCAGTCCACTTCCTTT
ASC AGTTTCACACCAGCCTGGAA TTTTCAAGCTGGCTTTTCGT
Caspase-1 AGCCACATCGCCAGACAC GCCCAATACGACCAAATCC
IL-1RA GGAAGATGTGCCTGTCCTGT CCTTCGTCAGGCATATTGGT
IL-10 AAGACCCAGACATCAAGGCG AATCGATGACAGCGCCGTAG
IL-37 CGATTCTCCTGGGGGTCTCT GCTTCATCAGTTTCTCCTTCTTCA
TGF-β GGTGGAAACCCACAACGAAAT GAGCAACACGGGTTCAGGTA
GAPDH AGCCACATCGCCAGACAC GCCCAATACGACCAAATCC
All primers were designed by using PrimerBLAST.
Canto II cytometer (BD Bioscience). Data were analyzed with
BDFACS Diva software (BD Bioscience).
Western Blot Analysis
Cell lysates were obtained from primed THP-1 cells or BMDM
after crystal stimulation. Cells were washed with ice-cold
PBS and lysed for 30min on ice with Triton X-100 based-
buffer plus phosphatase (orthovanadate, Sigma-Aldrich) and
protease inhibitor cocktail (Sigma-Aldrich). Cell lysates were
collected after centrifugation (7,500 g, 15min) and total protein
concentration was determined with the BCA Pierce Assay
(Thermo Fisher Scientific). An amount of 30µg protein was used
for SDS-PAGE separation and transferred to PVDF membranes
for western blot analysis. Anti-phosphorylated (P-) or total p38,
p42/44 (ERK1/2) and JNK rabbit mAbs (1/1,000), as well anti-
NLRP3 (1/500) rabbit mAbs were purchased from Cell Signaling.
Anti-tubulin pAb was from Santa Cruz Biotechnology (1/1,000),
anti-actin pAb was from Sigma-Aldrich (1/5,000).
Statistical Analysis
Data are reported as mean± SEM. After verification of Gaussian
distribution and homogenous variance of each group, two-
way ANOVA test or multiple t-test followed by false discovery
rate (FDR) correction were used to compare experimental
conditions. Otherwise, Kruskal-Wallis test with FDR correction
was chosen. For parametric or non-parametric tests, linear
correlation was determined by the non-parametric Spearman
test. The significance level was set at P < 0.05. GraphPad Prism
7.0 (San Diego, CA) was used for analysis.
RESULTS
Physicochemical and Morphological
Characteristics of CPP Phases
The physicochemical characterization of each CPP phase is
summarized in Table 2. Electron microscopy of each pure
synthetic CPP phases allowed for characterizing the different
morphologies of crystals or particles (Figure 1A). As observed
for biological specimens of CPPD crystals, the synthetic crystals
of the CPPD phases were acicular crystals, some arranged as
bundles, with large heterogeneity in size, and t-CPPD crystals
larger than m-CPPD crystals. Measured sizes were from 1 to
30µm for t-CPPD, with maximumwidth 5µm, and 1–25µm for
m-CPPD, with maximum width 1µm. m-CPPTβ had a faceted
plate morphology, with diameter up to 15µm. The a-CPP phase
appeared as round microparticles consisting of agglomerated
smaller particles of about 100 nm.On optical microscopy of THP-
1 cells cultured with CPP phases, m-CPPD crystals exhibited a
needle-shaped structure and were the smallest and were more
dispersed in cell culture than the others, whereas t-CPPD crystals
had a rectangular shape, m-CPPTβ crystals were platelet-like and
formed aggregates and the a-CPP phase corresponded to large
shapeless particles (Figure 1B).
Monoclinic CPPD Microcrystals Are the
Most Inflammatory CPP Microcrystals
We first assessed the inflammatory potential of different phases
of CPP crystals in vitro. In contrast of other pro-inflammatory
cytokines that required only a priming signal, IL-1β production
induced by microcrystals depends on 2 signals: first, a priming
signal through activation of innate immunity receptors such
as TLRs induces the synthesis and accumulation of proIL-1β,
the precursor form of the cytokine and second, a maturation
signal through NLRP3 inflammasome activation leads to IL-
1β secretion. Therefore, THP-1 and BMDM are primed with
PMA and LPS, respectively, to induce their activation and the
accumulation of proIL-1β, then stimulated with the four pure
and pyrogen-free synthetic CPP phases: m-CPPD, t-CPPD, m-
CPPTβ, and a-CPP phases (32). The effect of CPP crystals was
also compared to that of MSU crystals.
As compared with control stimulation, the amount of IL-
1β in cell culture medium increased with time after MSU,
m-CPPD, t-CPPD, and m-CPPTβ crystal stimulation; only
the a-CPP phase did not induce IL-1β secretion. IL-1β
production was dependent on crystal dose, 50µg/ml of m-
CPPD crystals induced high amount of IL-1β secretion while
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TABLE 2 | Physicochemical characteristics of the four CPP phases.
Size, length × width
(µm)
Specific surface area
(m2/g)
Morphology Aggregates
formed in culture
Ca/P atomic
ratio
m-CPPD 1–25 × 1 5.0 ± 0.2 Thin needles – 1.01 ± 0.02
t-CPPD 1–30 × 5 1.3 ± 0.1 Thick needles + 1.01± 0.02
m-CPPTβ 12–15 × 4 4.8 ± 0.2 Platelets +++ 1.00 ± 0.02
a-CPP 0.1 25.7 ± 0.5 Round shape aggregates of small particles ++ 1.00 ± 0.02
m- and t-CPPD, monoclinic and triclinic calcium pyrophosphate dihydrate; m-CPPTβ, monoclinic calcium pyrophosphate tetrahydrate β; a-CPP, amorphous CPP; Ca/P, calcium on
phosphorus molar ratio of the sample.
FIGURE 1 | Physicochemical and morphological characteristics of the four
CPP phases. (A) SEM micrographs of the four synthetic pure CPP phases
tested in this study (scale bar = 2µm). (B) Optical micrographs of
THP-1/crystal culture by EVOS system microscopy (X20).
the same concentration of t-CPPD and m-CPPTβ had no
effect on IL-1β production after 6 h stimulation (Figure 2A).
m-CPPD microcrystals rapidly induced IL-1β production,
which significantly increased after 1 h of crystal stimulation,
whereas the effect of t-CPPD and m-CPPTβ was delayed
(Figure 2B). Similarly, IL-8 production induced by m-CPPD
microcrystals began earlier than with the other microcrystals
(Figure 2C). In contrast, IL-6 production occurred later and
was evidenced only at 24 h of stimulation (Figure 2D). At
peak production, that is, 6 h after stimulation, and for a same
dose of crystals (200µg/ml), the amount of IL-1β and IL-8
induced by m-CPPD crystals was greater than that induced by t-
CPPD, m-CPPTβ, or MSU crystals (Figure 3A). The differential
inflammatory property of CPP microcrystals based on IL-1β/IL-
8 production by THP-1 cells was not correlated with the values
of the specific surface area (SSA) of the studied CPP phases
(Figure 3B).
Moreover, m-CPPD crystals had a higher capacity to
induce the expression of inflammatory cytokine genes (IL-
1β, IL-6, IL-8, TNF-α) on primed THP-1 cells, compared
to t-CPPD and m-CPPTβ crystals, but the a-CPP phase
did not induce gene expression (Figure 3C). The pattern
of production of IL-1β and IL-8 was strongly associated
with their gene expression profile. CPP microcrystals
also differentially modulated the gene expression of anti-
inflammatory cytokines. IL-1RA and IL-10 mRNA expressions
were higher at 6 h after stimulation with m-CPPD crystals
than t-CPPD and m-CPPTβ microcrystals; Transforming
growth factor-β1 (TGF-β1) expression was slightly decreased
only after m-CPPD crystal stimulation and IL-37 expression
was unchanged under all types of CPP crystal stimulation
(Figure 3D).
To confirm the different inflammatory properties, we
compared in vivo inflammation induced by m-CPPD and
t-CPPD microcrystals, the only two phases identified in
human synovial fluid, by using the murine air pouch model.
We assessed the kinetics of the inflammatory response
at 6 and 24 h after MSU, m-CPPD and t-CPPD crystal
injection (Figure 4). All three microcrystals conferred an
acute inflammatory reaction within 6 h, characterized by an
increase in cell number in the air pouch lavage (Figure 4A)
corresponding to high PMN recruitment (Figure 4B) and
an increase in IL-1β and CXCL1 production (Figure 4C).
CXCL1 level in the air pouch was positively correlated with
IL-1β level and cell infiltrates with IL-1β and CXCL1 levels
(Figure 4D).
At 24 h, according to the decrease in total cell number, PMN
infiltration induced by microcrystal injection was significantly
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FIGURE 2 | Kinetics of IL-1β, IL-8, and IL-6 production in response to CPP phases. THP-1 cells were primed the day before experiments. Cells were harvested at
different times of crystal stimulation as indicated. (A) IL-1β concentration was assessed in supernatant after 6-h stimulation with different doses of crystals. (B–D) Cells
were stimulated with 200µg/ml of different crystals and, at the indicated time, supernatants were collected to quantify IL-1β (B), IL-8 (C), and IL-6 (D) concentrations
(n = 3). Kruskal-Wallis test with FDR correction between crystal and PBS (#) or between CPP crystals (*). #,*p < 0.05; ##,**p < 0.01; ###,***p < 0.001.
FIGURE 3 | Differential effects of CPP phases on the inflammatory response in vitro. THP-1 were primed the day before experiments. After 6 h of crystal stimulation,
supernatants, and total RNA were collected. (A) IL-1β (n = 10) and IL-8 (n = 3) concentrations were quantified from cell supernatants by ELISA. Kruskal-Wallis test
with FDR correction between crystals and PBS (#) or between CPP crystals (*); (B) Correlation analysis between mean of IL-1β/IL-8 concentrations measured at 6 h
after crystal stimulation and specific surface area (S.S.A) of each CPP phase. Spearman t-test. (C,D) THP-1 cells were lysed for quantification of IL-1β, IL-6, IL-8, and
TNF-α (n = 10) and IL-1RA, IL-10, IL-37, and TGF-β (n = 3) mRNA expression by qPCR. Kruskal-Wallis test with FDR correction between crystal and PBS (#) or
between CPP phases (*). #,*p < 0.05; ##,**p < 0.01; ###,***p < 0.001.
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FIGURE 4 | CPP crystals differentially trigger inflammatory response in vivo. Air pouches were created by two injections of 3ml of sterile air at day 0 and day 3. At day
6, crystals or PBS were injected into the air pouches and inflammation was assessed 6 and 24 h after. (A–C) From the air pouch lavage, number of infiltrated cells was
evaluated by cell counting with Trypan blue exclusion (A); proportion of recruited neutrophils (PMN) and macrophages among total cells was determined by flow
cytometry after staining with anti-Ly6G-PE and F4/80-APC monoclonal antibodies (mAbs), respectively (B); IL-1β and CXCL1 concentrations were quantified by ELISA
(C). Two-way ANOVA with FDR correction between crystal and PBS at 6 h (#) or m-CPPD and other crystals ($) or between 6 and 24 h (*). #,$,*p < 0.05; ##,$$,**p
< 0.01; ###,$$$,***p < 0.001. (D) Correlation analysis between cell count and IL-1β (Left) or CXCL1 level (Middle) or between IL-1β and CXCL1 levels (Right), at 6 h
of crystal stimulation. Spearman test, *p < 0.05; **p < 0.01; ***p < 0.001.
decreased (m-CPPD 6 h: 86 ± 9%, 24 h: 63 ± 2%; t-CPPD 6
h: 59 ± 4%, 24 h: 31 ± 3%; MSU 6 h: 63 ± 1%, 24 h: 45 ±
2%; two-way ANOVA: p < 0.001), which suggests the initiation
of inflammation resolution. This finding was favored by the
substantial decrease in IL-1β production and the abolition of
CXCL1 production. The inflammation secondary to m-CPPD
microcrystals was higher and lasted longer than that induced by
t-CPPD and MSU microcrystals (Figure 4).
Taken together, these results confirmed that the four
CPP phases possessed different inflammatory properties,
with m-CPPD crystals being the most inflammatory,
followed by t-CPPD and m-CPPTβ, which had the same
inflammatory potential. By contrast, the a-CPP phase
was not inflammatory. All in vitro experiments of cell
stimulation by CPP phases have been performed in
FBS-free media. Therefore, the differential inflammatory
potential of the 4 CPP phases cannot be explained by crystal
coating.
CPP Crystal-Induced IL-1β Production
Depends on NLRP3 Inflammasome
Activation
NLRP3 inflammasome regulates IL-1β production induced by
MSU, BCP or a mixed of CPPD crystals (12, 15). Whether IL-
1β secretion induced by each pure phase of CPP crystals is
also NLRP3-dependent is unknown. Using a pharmacological
approach, we first observed that IL-1β maturation by different
CPP phases was secondary to caspase 1 (Casp1) activity.
Thus, CPP crystal-stimulated IL-1β production was drastically
decreased in primed THP-1 cells treated with a Casp1 inhibitor
(iCasp1) (Figure 5A, left). As expected, Casp1 inhibition did not
alter CPP crystal-induced IL-8 production (Figure 5A, right).
Then, we confirmed the role of NLRP3 inflammasome in
NLRP3 knock-out model. We observed that CPP crystal-induced
IL-1β production was abrogated in primed nlrp3−/− BMDM
(Figure 5B, left). Similarly, CPP crystal-induced IL-8 production
was unchanged in nlrp3−/− BMDM compared to wt BMDM
(Figure 5B, right). Next, we assessed whether CPP crystals
modulated the expression of NLPR3 and its complex-forming
partners, namely the adaptor protein ASC (Apoptosis associated
Speck-like protein containing a Caspase recruitment domain) and
Casp1. CPP crystals did not induce the gene expression of ASC
and pro-Casp1 but did differentially increase both the gene and
protein expression of NLRP3 (Figures 5C,D). Accordingly, the
effect of m-CPPD crystals was more important than t-CPPD
and m-CPPTβ crystals. And interestingly, the differential effect
on NLRP3 gene and protein expression was mild compared to
the differential effect observed for IL-1β, IL-8, IL-6, or TNF-
α production. In first conclusion, these results suggest that the
inflammatory potential of different CPP crystals is mediated
by their ability to differentially (i) amplify the priming signal
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FIGURE 5 | CPP crystal-induced IL-1β production is NLRP3-dependent. (A) Human IL-1β concentration from PMA-primed THP-1 cell cultures after 6 h stimulation by
different crystals in absence (PBS) or presence of caspase 1 inhibitor (iCasp1, 10µM, n = 5). Two-way ANOVA test with FDR correlation between PBS and iCasp1.
(B) Mouse IL-1β and CXCL-1 concentrations from wild type (wt, Left) and nlrp3−/− (Right) BMDM cultures (n = 6) after 6 h stimulation by different crystals. 2-way
ANOVA test with FDR correlation between crystal and PBS (#) or between CPP crystals (*). #,*p < 0.05; ##,**p < 0.01; ###,***p < 0.001. (C) mRNA
quantification of NLRP3, ASC and pro-Casp1 gene expression from PMA-primed THP-1 cells stimulated by different crystals. Kruskal-Wallis test with FDR correlation
between crystals and PBS (#) or between CPP crystals (*). #,*p < 0.05; ##,**p < 0.01; ###,***p < 0.001. (D) Immunoblot analysis of NLRP3 protein expression
from primed THP-1 cells or BMDM isolated from wt or nlrp3−/− mice (box in B) after 6 h of crystal stimulation; one representative of 3 independent experiments.
increasing the expression of multiple inflammatory cytokines,
and (ii) activate the NLRP3 inflammasome leading to IL-1β
production.
NF-κB Regulates CPPD
Microcrystal-Induced Inflammation
NF-κB is the main transcriptional factor leading to activation
of multiple pro- and anti-inflammatory gene expression
and therefore is strongly involved in microcrystal-induced
inflammation. Thus, we wondered whether the inflammatory
potential of different CPP crystals relied on their ability
to activate this transcription factor. We first observed that
primed THP-1 cell treatment with a pharmacological inhibitor
of NF-κB (BAY-11-7085) greatly abrogated the production of
IL-1β and IL-8 (Figure 6A) as well as the gene expression
of inflammatory cytokines including IL-1β, IL-8, IL-6, and
TNF-α (Figure 6B) induced by m-CPPD, t-CPPD, and m-
CPPTβ microcrystals, as MSU crystals. Interestingly, BAY-11-
7085 dose-dependently inhibited m-CPPD crystal-induced IL-1β
production (Figure S1A, left).
Then, we observed that the differential capacity of each
phase of CPP crystals to induce proIL-1β formation was
completely abolished by NF-κB inhibitor treatment (Figure 6C).
This finding suggests that the decreased secretion of mature
IL-1β was at least secondary to the inhibition of the first
signal. To reveal NF-κB activation induced by crystals, we
stimulated THP-1-Lucia cells containing a NF-κB-inducible
luciferase reporter plasmid with the microcrystals. The ability
to stimulate NF-κB was higher with m-CPPD than t-CPPD and
MSU microcrystals (Figure 6D). Next, we validated the role of
NF-κB in vivo. Indeed, PMN infiltration into the air pouch -
defined by i) total cell count (Figure 7A), ii) absolute number
and percentage of PMN or macrophages (Mø) (Figures 7B,C),
and iii) production of IL-1β and CXCL1 (Figure 7D) - induced
by m-CPPD microcrystals were greatly inhibited in mice pre-
treated with the NF-κB inhibitor before crystal injection into the
air pouch.
These results further demonstrate that the inflammatory
response induced by CPP crystals is NF-κB-dependent, whatever
the type of crystal, and that the inflammatory properties of m-
CPPD, t-CPPD, and MSU crystals can be explained by their
ability to differentially induce NF-κB signaling.
CPPD Crystals Activate NF-κB via MAPK
Pathways
NF-κB can be activated by several intracellular signaling
pathways including TLR and MAPK pathways, both involved
in CPP microcrystal-induced cell stimulation (13, 19). Thus,
we evaluated - on primed THP-1 cells - whether the capacity of
CPP crystals to activate NF-κB depended on p38, ERK1/2 and/or
JNK MAPK pathways. As expected, we observed by immunoblot
analysis that m- and t-CPPD crystals differentially stimulated
the phosphorylation of these three MAPK pathways, with the
effect of m-CPPD crystals again the most important (Figure 8A).
Pharmacological inhibition of p38, JNK, or p42/44 (ERK1/2)
MAPK decreased NF-κB activation induced by m-CPPD crystals
(Figure 8B). Finally, IL-1β and IL-8 production induced by
m-CPPD and t-CPPD were both substantially decreased by
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FIGURE 6 | NF-κB regulates CPPD microcrystal-induced inflammation. Cells were primed the day before experiments. (A–C) 6 h after crystal stimulation of THP-1
cells, in the absence (PBS) or presence of NF-κB inhibitor (BAY-11-7085 [iNF-κB], 10µM), supernatants were collected to quantify IL-1β (n = 5) and IL-8 (n = 3)
concentrations (A), and cells were lysed for analyzing IL-1β, IL-6, IL-8, and TNF-α gene expression by qPCR (n = 4) (B) or proIL-1β protein expression by western blot
analysis (one experiment representative of three) (C). Two-way ANOVA test with FDR correction: *p < 0.05; **p < 0.01; ***p < 0.001 (iNF-κB compared to PBS). (D)
8 h after crystal stimulation, supernatants of THP-1-Lucia cells were collected to determine the activity of secreted luciferase. Results are reported as relative NF-κB
activity (n = 8); Kruskal-Wallis test with FDR correction between crystal and PBS (#) or between CPP crystals (*). #*p < 0.05; ##**p < 0.01; ###***p < 0.001.
HKLM, heat-killed Listeria monocytogenes.
JNK and ERK1/2 MAPK inhibitors (Figure 8C) but were not
modulated by the p38 MAPK inhibitor (Figure 8D). Both JNK
and ERK1/2 MAPK inhibitors dose-dependently decreased
m-CPPD crystal-induced IL-1β production (Figure S1A).
Inhibition of JNK MAPK inhibition did not modify m-CPPD
crystal-induced ERK and p38 MAPK activation. Similarly,
ERK MAPK pathway inhibition did not alter m-CPPD
crystal-induced JNK and p38 activation. In contrast, p38
MAPK inhibition increased JNK and ERK MAPK activation
induced by m-CPPD crystals (Figure S1B). These results
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FIGURE 7 | NF-κB regulates m-CPPD microcrystal-induced inflammation in
vivo. Six hour after PBS or m-CPPD injection into the air pouches, in absence
(PBS) or in presence of iNF-κB, the air pouch exudates were collected for
analysis. (A) The number of total infiltrated cells was evaluated by cell counting
with Trypan blue exclusion. (B,C) the absolute number (Left) and proportion
(Right) of recruited neutrophils (PMN) and macrophages (Mø) among total cells
was determined by flow cytometry after staining with anti-Ly6G-PE and
F4/80-APC mAbs, respectively. (D) IL-1β and CXCL1 levels were quantified by
ELISA. Kruskal-Wallis test with FDR correction between crystal and PBS (#) or
between CPP crystals (*). #*p < 0.05; ##**p < 0.01; ###***p < 0.001.
suggest that the inflammatory potential of CPP crystals depends
on NF-κB activation induced by JNK and ERK1/2 MAPK
pathways.
DISCUSSION
In this study, we report for the first time on the individual
biologic inflammatory properties of four different CPP phases
that have been recently fully described and characterized
according to their large variability of morphology and size
(4, 32). In contrast to most previous studies that assessed
the cellular effects of mixed m-CPPD and t-CPPD crystals or
poorly characterized CPPD crystals, we evaluated the biological
properties of pure monophasic CPP particles. We observed a
clear disparity effect of m-CPPD, t-CPPD, m-CPPTβ and a-
CPP phases on inflammatory reactions. m-CPPD crystals were
the most phlogistic crystals, followed by t-CPPD and m-CPPTβ,
whereas a-CPP particles did not harbor inflammatory potential.
The inflammation induced by m-CPPD crystals was more rapid
and intense and lasted longer than that induced by t-CPPD and
m-CPPTβ crystals. This disparity in response was observed in
vitro and in vivo on the synthesis signal of pro-inflammatory
cytokines (mediated by NF-κB and MAPK kinase activation)
especially on the formation of immature pro-IL-1β as well as
secretion of mature IL-1β, the central cytokine driving the
microcrystal-induced arthritis (Figure 9). As for other particles,
IL-1β production induced by each pure phase of CPP crystals was
also dependent on NLRP3 inflammasome (17).
CPP crystal inflammatory properties depend on the potential
induction of major inflammatory cytokines other than IL-
1β, including IL-8, IL-6, and TNF-α. The role of IL-8 in
CPPD and MSU crystal-related diseases is suggested in human
diseases when IL-8 level is increased in serum and synovial
fluid during gout and pseudo-gout flares, respectively (33,
34). Several in vitro and in vivo studies reveal the critical
role of IL-8 in PMN recruitment and activation during
MSU crystal-induced inflammation (35–38). Thus, blocking
IL-8 activity by deleting its receptor CXCR2 or by anti-IL-8
antibody treatment abrogates neutrophil infiltration in mouse
experimental models of MSU crystal-induced inflammation
(36, 37). In contrast, until now, we lacked in vivo data of
the role of IL-8 in CPPD crystal-related inflammation. Roch-
Arveiller et al. previously showed that injection of m-CPPD
crystals into the rat pleural cavity induced stronger and longer
PMN recruitment than did injection of t-CPPD crystals (10).
However, the authors did not evaluate the production of IL-
1β and IL-8 or the involved intracellular signaling pathways.
Moreover, the available in vitro data do not differentiate the
individual effect of each type of CPP crystals on IL-8 production
(38, 39). Here, we report that m-CPPD crystals, the most
inflammatory CPP crystals, induced the highest level of IL-8
both in vivo and in vitro, which was correlated in vivo with
IL-1β production and PMN recruitment at the site of crystal
injection.
Therefore, our findings give some hints to explain the wide
clinical spectrum associated with CPP crystal deposition. As
suggested by Swan et al. (7), acute CPP crystal-associated
inflammatory arthritis might be secondary to the presence of a
large amount of CPP crystals with high inflammatory potential
such as m-CPPD crystals, whereas asymptomatic CPPD might
be associated with deposition of low-inflammatory CPP crystals
such as t-CPPD or their potential precursors m-CPPTβ or a-
CPP. This hypothesis needs to be confirmed by clinical studies
assessing the precise phase of CPP compounds according to
clinical phenotype.
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FIGURE 8 | CPPD microcrystals activate NF-κB and induce inflammation via MAPK pathways. Cells were primed the day before experiments. (A) THP-1 cells were
incubated for 30min with crystals then lysed for immunoblot analysis of p38, p42/44, and JNK MAPK phosphorylation (one experiment representative of three). (B–D)
Cells were stimulated with crystals in the absence (PBS) or presence of p38 (SB203580 (ip38), 10µM), JNK (SP600125 (iJNK), 10µM) or p42/44 (PD98059 (ip42/44),
100µM) inhibitors. (B) THP-1-Lucia cell supernatants were collected at 8 h for determining luciferase activity (n = 4). HKLM, heat-killed Listeria monocytogenes. (C,D)
THP-1 supernatants were collected at 6 h (C: ip42/44 and iJNK) or at 2 h (D: ip38) to quantify IL-1β and IL-8 levels by ELISA (n = 4). Multiple t-test with FDR
correction PBS and MAPK inhibitors (*). *p < 0.05; **p < 0.01; ***p < 0.001.
In this study, we also confirmed that NF-κB was a major
transcription factor involved in regulating IL-1β, IL-6, IL-8, and
TNF-α gene expression induced by CPP crystals. Moreover,
the inflammatory potential of each CPP phase tested to induce
these genes depended on their ability to stimulate NF-κB
activity via MAPK pathways, acting in synergy with PMA
or LPS priming. Accordingly, previous groups showed that
MSU crystal-induced IL-1β production was amplified by LPS
or fatty acid priming (24, 40). In agreement with Liu et al.
(38, 41) and Jaramillo et al. (28), we found that MSU and
CPPD crystal-induced NF-κB activation depends on ERK1/2
and JNK MAPKs. Interestingly, we observed that the role of
p38 MAPK in NF-κB activation differed for m-CPPD and t-
CPPD crystals; the p38 MAPK inhibitor partially decreased m-
CPPD crystal-induced NF-κB activation but had no effect on
t-CPPD crystal-induced NF-κB activation. Also, p38 inhibition
did not modify IL-1β production induced by m-, t-CPPD
and MSU crystals while it decreased NF-κB activation induced
by CPPD crystals. It might be secondary to off-target effects
of the pharmacologic p38 inhibitors (42), especially on JNK
and ERK MAPK activation (see Figure S1B). Nevertheless,
these results suggested, first, the major role of JNK and
ERK MAPK pathways, and second, the involvement of other
transcription factors in CPP crystal-stimulated IL-1β production
(43).
How CPPD crystals differentially activate intracellular
signaling pathways remains unknown. In this study, the
inflammatory potential of each studied CPP phase was not
correlated with the value of SSA. Previous studies suggested
that the inflammatory potential of microcrystals relied on
their physicochemical characteristics including morphology,
size, crystal-specific surface area and properties including
crystal surface charge (or zeta potential), roughness and
ability to adsorb proteins (6, 8, 10, 18, 21, 44). Most of these
studies assessed basic calcium phosphate (BCP) and especially
hydroxyapatite (HA) crystals. However, the role of these
different crystal parameters varies depending on the study,
and conflicting results are reported in the literature on the
effect of crystal size, crystal-specific surface area and charge.
Previously, we observed that the inflammatory potential of
different BCP crystals including octacalcium phosphate, HA
and carbonated-apatite crystals was correlated with specific
surface area (8). In contrast, a few studies reported that
inflammatory properties of HA crystals depended on their
size and shape but not surface topography, surface charge
or specific surface area. Thus, small and needle-shape HA
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FIGURE 9 | Schematic representation of the inflammatory potential of CPP crystals relying on both NF-κB (priming signal) and NLRP3 inflammasome (maturation
signal) activation. (A) In our in vitro model of macrophages (THP-1 or BMDMs), uncoated CPP crystals act in synergy (red arrows) with PMA or LPS used for cell
differentiation and activation. We showed that CPP crystals amplify NF-κB activation through a MAPK-dependent signaling pathways leading to an increased
production of pro-inflammatory cytokines including TNF-α, IL-8, IL-6, and pro-IL-1β (A, left: priming signal). CPP crystals also enhance NLRP3 production and
activation that induces ASC and pro-caspase-1 oligomerization (NLRP3 assembly) leading to caspase-1 maturation and subsequently cleavage of pro-IL-1β into
active IL-1β (A, right: maturation signal). (B) CPP crystals possess different inflammatory properties with m-CPPD crystals being the most phlogistic ones followed by
t-CPPD and m-CPPTβ, while a-CPP phase does not harbor inflammatory response. The inflammatory potential of each crystal depends on their ability to differentially
activate the MAPK/NF-κB pathways and NLRP3 inflammasome complex. How CPP crystals differentially modulate NF-κB and NLRP3 remains unknown.
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crystals induced the strongest NLRP3 inflammasome activation
and IL-1β production as well as TNF-α, IL-6, and IL-10
production, with limited responses triggered by larger crystals
or similar-sized spherical and smooth particles (6, 44). These
small-sized microcrystals were more efficiently internalized by
monocytes or macrophages, and the amount of internalized
crystals was correlated with inflammatory cytokine production
(6, 45).
Besides crystal size, crystal morphology and surface charge
also modulate cellular internalization capacity. Thus, more than
80% of positively charged particles were internalized after 1
h-incubation as compared with less than 5% of negatively
charged particles (45). In our study, in contrast to BCP
crystals, the inflammatory potential of the different CPP phases
was mainly correlated with their structure (type of phase).
Whether the inflammatory potential of CPP crystals is correlated
with the amount of internalized crystals needs further study.
Similarly, whether crystal aggregate formation modulates crystal
phagocytosis and cellular responses deserves more investigation.
Crystal-induced cellular responses can be modulated by
the ability of crystals to interact with the cell membrane.
These interactions might occur through crystal surface charge,
proteins adsorbed at the crystal surface, specific membrane
receptors, channels or yet to be identified crystal receptors
(17). The cellular effects of MSU and CPPD crystals, especially
their inflammatory potential, are well known to be modulated
by proteins adsorbed at the crystal surface (46–51). Thus,
adsorption of apolipoprotein B on MSU crystals abrogates their
inflammatory potential, whereas adsorption of immunoglobulin
G (IgG) increases their inflammatory potential (46, 47). Similarly,
t-CPPD crystals coated with serum proteins or IgG are more
inflammatory than are uncoated t-CPPD crystals, whereas m-
CPPD crystals coated with IgG are less inflammatory than
are uncoated m-CPPD crystals (49, 50). Proteins adsorbed
on MSU crystals change during inflammatory reaction, which
suggests that adsorbed proteins are not strongly bound to the
microcrystal surface (46, 47, 51). Whether the inflammatory
potential of CPP crystal phases is secondary to their ability to
adsorb different proteins remains unknown. A direct interaction
between CPP crystals and cells is also hypothesized. Indeed, the
simple atomic motif of the most developed face of t-CPPD could
potentially destroy the double layer arrangement of phospholipid
cell membranes (52). The differences between the crystalline
structures of the CPP phases could then affect the ability to
adsorb proteins. The organization of atoms and molecules on
the surface of the different CPP crystals, and a fortiori on the
a-CPP phase, presents a wide variety of configurations. The
pyrophosphate molecule orientation and the number of calcium
vary considerably between the fully hydrated basal surface of
m-CPPTβ with no pyrophosphate molecules on the surface
and the m-CPPD crystal faces with pyrophosphate molecules
exposed almost parallel to this surface (53). Hence, the m-
CPPD crystals could present enhanced properties of interaction
with the environment, which could be responsible for its higher
inflammatory property.
Because our experiments were performed with serum-
free media, the CPP crystal inflammatory properties could
essentially depend on their direct interaction with the plasma
cell membrane. This hypothesis is further supported by the
opposite effect reported with IgG coating on t-CPPD and m-
CPPD crystals (49, 50). Moreover, direct interactions between
crystals and the plasma cell membrane are strongly emphasized
by the rapid activation of intracellular calcium mobilization
and MAPK signaling pathways that occur within 1min of
crystal incubation (27, 54). Ng et al. nicely showed by atomic
force microscopy that MSU crystals interacted with the cell
membrane, which resulted in membrane cholesterol lipid sorting
and intracellular recruitment of Syk kinase-dependent signaling
and NLRP3 inflammasome activation (18). Recently, Hari et al.
demonstrated that MSU crystals activated IL-1β production in
the absence of phagocytosis; MSU crystals trapped at the bottom
of the culture plate with a thin layer of epoxy were still able
to activate macrophage inflammasome and IL-1β production
(21).
In conclusion, our comparative study highlighted a
differential inflammatory capacity of four different CPP
phases. The three CPP crystals induced an NF-κB-dependent
inflammatory response, each with a different level of pro-
inflammatory cytokine expression and production, with
m-CPPD the most powerful inflammatory crystal compared
to t-CPPD and then m-CPPTβ. Also, we demonstrated for
the first time that this inflammatory potential is explained
by the ability of the crystals to differentially activate the
MAPK-dependent NF-κB pathway. Finally, assessing how
different CPP phases interact with the cell membrane
would give insights into mechanisms that modulate the
CPP crystal inflammatory potential and might explain the
wide clinical phenotypes related to cartilage CPPD crystal
deposition.
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Figure S1 | Inhibitors of NF-κB and MAPK pathways dose-dependently decrease
IL-1β production. THP-1 cells were primed the day before experiments. Then, cells
were stimulated by m-CPPD crystals in the absence or presence of different doses
of NF-κB [BAY-11-7085 (iNF-κB): 1–10µM], JNK [SP600125 (iJNK): 0.1–10µM],
p42/44 [PD98059 (ip42/44): 1–100µM] or p38 [SB203580 (ip38): 0.1–10µM]
inhibitors. (A) Cell supernatants were collected at 6 h of stimulation to quantify
IL-1β by ELISA (n = 3). (B) Cell lysates were collected at 30min of stimulation to
assess MAPK activation by immunoblot (one experiment representative of
three).
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